Investigational Drug Information for SD-809
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
What is the drug development status for SD-809?
SD-809 is an investigational drug.
There have been 10 clinical trials for SD-809.
The most recent clinical trial was a Phase 3 trial, which was initiated on August 5th 2013.
The most common disease conditions in clinical trials are Dyskinesias, Movement Disorders, and Tourette Syndrome. The leading clinical trial sponsors are Teva Branded Pharmaceutical Products R&D, Inc., Auspex Pharmaceuticals, Inc., and Teva Branded Pharmaceutical Products, R&D Inc.
There are twenty-two US patents protecting this investigational drug and two hundred international patents.
Summary for SD-809
| US Patents | 22 |
| International Patents | 200 |
| US Patent Applications | 127 |
| WIPO Patent Applications | 105 |
| Japanese Patent Applications | 28 |
| Clinical Trial Progress | Phase 3 (2013-08-05) |
| Vendors | 23 |
Recent Clinical Trials for SD-809
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy | Teva Branded Pharmaceutical Products R&D, Inc. | Phase 3 |
| A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy | Teva Branded Pharmaceutical Products, R&D Inc. | Phase 3 |
| A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents | Teva Branded Pharmaceutical Products R&D, Inc. | Phase 3 |
Clinical Trial Summary for SD-809
Top disease conditions for SD-809
Top clinical trial sponsors for SD-809
US Patents for SD-809
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| SD-809 | ⤷ Sign Up | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Sign Up |
| SD-809 | ⤷ Sign Up | Oral drug dosage forms having desired drug release profiles and uses thereof | Triastek, Inc. (Nanjing, CN) | ⤷ Sign Up |
| SD-809 | ⤷ Sign Up | Treating extrapyramidal syndrome using trapidil | SINOPIA BIOSCIENCES, INC. (San Diego, CA) | ⤷ Sign Up |
| SD-809 | ⤷ Sign Up | Compartmented pharmaceutical dosage forms | Triastek, Inc. (Nanjing, CN) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for SD-809
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| SD-809 | Australia | AU2017261372 | 2036-05-05 | ⤷ Sign Up |
| SD-809 | Canada | CA3023278 | 2036-05-05 | ⤷ Sign Up |
| SD-809 | China | CN107847398 | 2036-05-05 | ⤷ Sign Up |
| SD-809 | European Patent Office | EP3452003 | 2036-05-05 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
